Food safety compliance is measured through several connected systems: regulatory inspections, import screening, laboratory testing, noncompliance rates, disease surveillance, and outbreak investigations. The latest available figures show both the scale of oversight and the limits of any single measure. FDA and USDA workloads span millions of decisions and products, while CDC and European Union surveillance show the illnesses and outbreaks that remain visible after controls are applied.
Contents
- FDA food-establishment oversight
- FDA import and state-contract controls
- USDA inspection scale and compliance thresholds
- What U.S. multistate outbreak investigations found
- European Union foodborne disease burden
- How outbreak evidence targets controls
FDA food-establishment oversight
The FDA’s Fiscal Year 2024 justification estimated 7,661 unique domestic food-establishment inspections in the United States and 1,230 unique foreign food-establishment inspections. Together, the estimate was 8,890 unique food-establishment inspections. These are estimates for FY 2024, not a retrospective count of completed inspections.
The same FDA estimate included several different types of oversight activity. It projected 2,082 domestic food field exams and tests and 15,164 domestic food laboratory samples analyzed. It also projected 7,106 unique state-contract food-establishment inspections. When the categories were combined in the FDA’s reported measure, the grand total of food-establishment inspections was estimated at 15,997.
These figures illustrate why “inspection volume” needs a definition. A unique establishment inspection, a field exam, a laboratory sample, and a state-contract inspection are different activities. They may support the same compliance objective, but they should not be treated as interchangeable units. The FDA’s published source is the FDA Fiscal Year 2024 Justification of Estimates for Appropriations Committees.
For a food business, the practical implication is that compliance can be examined through more than an on-site visit. Sampling and laboratory analysis are separate parts of the oversight picture, and state-contract work adds another layer to the federal program’s reported workload. The figures do not state that every establishment received the same type or frequency of review.
FDA import and state-contract controls
FDA’s FY 2024 estimate projected 140,673 import field exams and tests for food, alongside 17,609 import food laboratory samples analyzed. The estimate for total import physical exams was 158,282. At the document and line-decision level, FDA estimated 19,732,920 food import line decisions.
The estimated physical-examination rate was 0.80% of food import lines. That percentage is a measure of the estimated share physically examined; it is not a claim that the remaining lines were risk-free or exempt from all regulatory review. Import decisions can involve other screening and compliance processes, while physical examination is one specific activity.
FDA also estimated 6,263 state-contract food-safety inspections outside HACCP, 679 state-contract domestic seafood HACCP inspections, and 101 state-contract low-acid canned-food or acidified-food inspections. The estimated state-contract food funding for FY 2024 was $13,037,828. All of these FDA figures are FY 2024 estimates reported in the FDA Fiscal Year 2024 Justification of Estimates for Appropriations Committees.
| FDA FY 2024 estimate | Measure |
|---|---|
| Food import line decisions | 19,732,920 |
| Import physical exams | 158,282 |
| Import field exams and tests | 140,673 |
| Import laboratory samples analyzed | 17,609 |
| Estimated food import lines physically examined | 0.80% |
The comparison shows the different scales involved in import compliance. Line decisions were estimated in the tens of millions, while physical exams and laboratory samples were counted in the hundreds of thousands and tens of thousands. None of these figures alone describes overall compliance performance; each describes a different point in the control system.
USDA inspection scale and compliance thresholds
USDA’s Food Safety and Inspection Service reported that its inspection personnel conducted 7.7 million food-safety and food-defense procedures across 7,100 USDA-regulated establishments in 2024. FSIS also inspected more than 163 million head of livestock, 9.8 billion poultry carcasses, and 2.8 billion pounds of liquid, frozen, and dried egg products during 2024. These are reported 2024 activity and product-volume figures from Food Safety Stats.
The product figures show why USDA compliance statistics cover more than facility counts. A relatively small number of regulated establishments can be associated with very large livestock, poultry, and egg-product volumes. The reported 7.7 million procedures are also not the same as the number of establishments or products; they represent food-safety and food-defense procedures performed by inspection personnel.
FSIS also publishes public-health-risk evaluation cut points for FY 2025. For processing-only operations, the lower noncompliance-rate cut point was 2.35% and the upper cut point was 3.50%. For combination slaughter-and-processing operations, the lower cut point was 3.71% and the upper cut point was 6.02%.
| FSIS FY 2025 operation type | Lower cut point | Upper cut point |
|---|---|---|
| Processing-only | 2.35% | 3.50% |
| Combination slaughter-and-processing | 3.71% | 6.02% |
These cut points are evaluation thresholds for the stated FY 2025 public-health-risk analysis. They should not be presented as a universal legal pass/fail rate for every food business. The source is FSIS Data Analysis and Reporting: Public Health Regulations FY 2025.
What U.S. multistate outbreak investigations found
CDC investigated 181 possible multistate enteric outbreaks during 2023. Of those, 84 were determined to be outbreaks. Investigators solved 50 of the 84, identifying a suspected source for 22 and a confirmed source for 28. The distinction matters: a suspected source and a confirmed source are not equivalent levels of evidence.
The 84 multistate outbreaks determined to be outbreaks resulted in 3,153 reported illnesses, 942 reported hospitalizations, and 10 reported deaths. These totals describe reported outcomes associated with the outbreaks in CDC’s 2023 summary; they are not an estimate of all foodborne illness in the United States.
Food was the link for 32 of the 50 solved multistate outbreaks. Those solved foodborne outbreaks caused 1,219 illnesses, 421 hospitalizations, and 9 deaths. Animal contact was linked to 18 solved outbreaks, which caused 1,220 illnesses and 290 hospitalizations. The categories describe the solved outbreaks in the CDC summary and should not be added together as if they were population-wide disease totals.
Salmonella accounted for 54 of the 84 multistate outbreaks investigated in 2023. The number refers to outbreaks investigated, not to the number of illnesses or the proportion of all Salmonella infections. The detailed source is CDC’s Summary of Possible Multistate Enteric (Intestinal) Disease Outbreaks in 2023.
European Union foodborne disease burden
EU surveillance recorded 148,181 campylobacteriosis cases in 2023, with a notification rate of 45.7 cases per 100,000 people. It recorded 77,486 salmonellosis cases, with a rate of 18 cases per 100,000 people. The salmonellosis notification rate increased 16.9% from 2022 to 2023.
For other monitored infections, EU surveillance recorded 10,217 Shiga toxin-producing E. coli infection cases in 2023, at 3.1 cases per 100,000 people. That notification rate increased 30% from 2022 to 2023. There were 8,738 yersiniosis cases, at 2.4 per 100,000 people, and 2,952 confirmed invasive listeriosis cases, at 0.66 per 100,000 people. The listeriosis notification rate increased 5.8% from 2022 to 2023.
| Infection reported in the EU | Cases in 2023 | Notification rate |
|---|---|---|
| Campylobacteriosis | 148,181 | 45.7 per 100,000 |
| Salmonellosis | 77,486 | 18 per 100,000 |
| Shiga toxin-producing E. coli infection | 10,217 | 3.1 per 100,000 |
| Yersiniosis | 8,738 | 2.4 per 100,000 |
| Invasive listeriosis | 2,952 | 0.66 per 100,000 |
EU countries reported 5,691 foodborne outbreaks in 2023. Those outbreaks involved 52,127 reported human cases, 2,894 hospitalizations, and 65 deaths. The European surveillance report also found that only 15 EU Member States met all established Salmonella-reduction targets for poultry populations in 2023, compared with 19 in 2022.
The highest reported share of ready-to-eat food samples exceeding the 100 CFU/g Listeria safety limit was 0.78% for fermented sausages in 2023. This is a reported share for that food category and limit; it does not mean that 0.78% of all ready-to-eat foods exceeded the limit. These EU figures are from The European Union One Health 2023 Zoonoses Report.
How outbreak evidence targets controls
Outbreak data can help regulators connect illnesses with food categories and prioritize preventive controls. The CDC’s IFSAC analysis identified 4,156 outbreaks from 1998 through 2023 that were confirmed or suspected to be caused by Salmonella, E. coli O157, or Listeria. The long period and the three pathogens make this an evidence base for pattern analysis, not a count of current-year outbreaks.
Within that analysis, 1,390 outbreaks had an implicated food that could be assigned to one of 17 food categories. The single-food-category dataset contained 1,037 Salmonella outbreaks, 285 E. coli O157 outbreaks, and 68 Listeria outbreaks. These are dataset counts within the specified IFSAC analysis, not estimates of the total number of outbreaks caused by those pathogens.
For compliance planning, the value of such evidence is its connection between hazard, food category, and control point. Inspection workloads indicate where oversight is applied; noncompliance thresholds provide defined evaluation bands for particular FSIS operations; and outbreak surveillance shows where failures can produce measurable public-health consequences. The IFSAC source is the IFSAC 2023 Annual Report.
The figures also show why compliance programs should preserve scope and measurement dates. FDA’s numbers are FY 2024 estimates, USDA’s production and procedure figures are for 2024, FSIS cut points are for FY 2025, CDC’s multistate outbreak summary covers 2023, and the EU disease and outbreak figures cover 2023. Comparing them requires keeping their geography, definitions, and time periods explicit.